The type of oral anticoagulant – DOACs versus vitamin K antagonists (VKA) – has no influence on mortality following upper GI bleeding. A French study of 475 consecutive patients with upper GI bleeding before or during hospital admission found slightly more than half (54.6%) were on VKA antagonists as opposed to DOACs. Baseline characteristics were ...
Upper GI bleeds: comorbidities more important than choice of anticoagulant
By Mardi Chapman
25 Feb 2021